2022
Correction to: Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
Gianakos A, Saad B, Haring R, Menken L, Elkattaway S, Liporace F, Yoon R. Correction to: Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty. Patient Safety In Surgery 2022, 16: 1. PMID: 34996502, PMCID: PMC8742330, DOI: 10.1186/s13037-021-00313-6.Peer-Reviewed Original Research
2020
Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients
Buzin S, Gianakos A, Li D, Viola A, Elkattawy S, Keller D, Yoon R, Liporace F. Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients. Patient Safety In Surgery 2020, 14: 6. PMID: 32015758, PMCID: PMC6990520, DOI: 10.1186/s13037-020-0230-4.Peer-Reviewed Original ResearchHigher pain scoresLiposomal bupivacainePain scoresRisk factorsPain managementOpioid useYounger patientsRandomized trialsTotal hipKnee arthroplastyRevision arthroplastyMulti-modal pain managementRetrospective observational cohortPain management protocolTotal knee arthroplastyPostoperative painObservational cohortActive smokersOutcomes RegistryInfection/Primary THAResultsA totalRetrospective analysisExclusion criteriaBupivacaine
2018
Reduction of Blood Loss by Tranexamic Acid Following Total Hip and Knee Arthroplasty
Gianakos A, Hurley E, Haring R, Yoon R, Liporace F. Reduction of Blood Loss by Tranexamic Acid Following Total Hip and Knee Arthroplasty. JBJS Reviews 2018, 6: e1. PMID: 29738409, DOI: 10.2106/jbjs.rvw.17.00103.Peer-Reviewed Original ResearchConceptsIA TXATotal knee arthroplastyTotal blood lossTotal hip arthroplastyBlood lossTranexamic acidKnee arthroplastyIA administrationStandardized mean differenceHospital stayThromboembolic complicationsHip arthroplastyTXA administrationCohort studyDrain outputTotal hipIntra-articular tranexamic acidWeight-based protocolRetrospective cohort studyProspective cohort studySymptomatic thromboembolic complicationsOverall blood lossCochrane Library databasesTherapeutic Level IIIStandard dose